Sirtex – Australian National University

Liver Cancer Treatment

Sirtex is doing research to develop and commercialise effective treatments for liver cancer using novel small particle technology. They have developed an innovative means of treating liver cancer in cases where it is not possible to surgically remove the liver tumours. Their product can be used to deliver targeted, internal irradiation therapy directly to the tumour where it remains, having its impact only on the affected organ. This new therapy is called Selective Internal Radiation Therapy also know as SIRT. Nano-beads loaded with a radioactive isotope can be studied in detail and tracked using cryo-scanning electron microscopy, thereby providing important information to the researchers.

Sirtex has worked with the Australian National University node of the AMMRF to improve delivery of SIRT through the application of nano-particulate technology.

Related Stories

Cutting-edge alloys are big business

Through an ARC Linkage Project, Weir Minerals access sophisticated microscopy in the AMMRF at the University of Sydney. The researchers are developing new super-tough alloys to keep their mining machinery at the leading edge of the market. Weir ...


BlueScope Steel – University of Sydney

Bluescope Steel developed processing technology (Castrip®) to directly cast molten metal into strip steel and established a global joint venture to commercialise the technology. The first production plant using the technology is in the USA and has ...


Queensland Art Gallery – University of Queensland

Zinc oxide has been industrially produced as a white pigment for painting since the 1840s. Unfortunately its presence has recently been linked to serious deterioration resulting from reaction of zinc oxide with fatty acids from the oil-based ...